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Abstract: The deleterious effects of nicotine on various health conditions have been well documented.
Although many orthopedic diseases are adversely affected by nicotine, little is known about its
preclinical effects on chondrogenesis or osteogenesis, cartilage formation, osteoarthritis (OA),
and osteochondral repair. A systematic review was conducted examining the current scientific
evidence on the effects of nicotine on chondrogenesis or osteogenesis in vitro, possible consequences
of prenatal nicotine exposure (PNE) on cartilage and OA susceptibility in the offspring, and
whether nicotine affects OA development and osteochondral repair in vivo, always focusing on their
underlying mechanisms. The data reveal dose-dependent effects on articular chondrocytes and on
the chondrogenesis and osteogenesis of medicinal signaling cells in vitro, with lower doses often
resulting in positive effects and higher doses causing negative effects. PNE negatively affects articular
cartilage development and induces OA in the offspring without or with nicotine exposure. In contrast,
protective effects on OA development were only reported in monosodium iodoacetate-induced small
animal models. Finally, nicotine repressed MSC-based osteochondral repair in vivo. Future studies
need to investigate dose-dependent clinical effects of smoking on cartilage quality in offspring,
OA susceptibility and progression, and osteochondral repair more in detail, thus identifying possible
thresholds for its pathological effects.
Keywords: systematic review; smoking; nicotine; cigarette; cartilage; articular cartilage;
chondrocyte; osteoarthritis
1. Introduction
Articular cartilage, the gliding tissue that covers the ends of bones, has a limited capacity to
repair [1]. Osteoarthritis (OA) and focal (osteo-)chondral defects caused by trauma or osteochondral
diseases, such as osteochondritis dissecans are often debilitating conditions chiefly affecting the
articular cartilage, besides the subchondral bone and all other tissues forming diarthrodial joints [2–4].
Nicotine, the principal pharmacologically active component of smoking tobacco, smokeless tobacco,
and e-cigarettes, has been long recognized as an important influencer of cartilage formation and
OA [5–9].
Although many musculoskeletal conditions are complicated and adversely affected by cigarette
smoking, including fracture repair and osteoporosis, spinal fusion, and degenerative disc disease,
divergent data exist on the precise effects of nicotine on osteochondrogenesis and OA development
due to the diversity of previous evidence from both preclinical and clinical trials [10–14]. For example,
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several epidemiological studies support the hypothesis that smoking may prevent OA [5,6,12,15,16];
however, preclinical studies indicate that prenatal nicotine exposure (PNE) suppressed insulin-like
growth factor I (IGF-I) expression in fetal articular chondrocytes and down-regulated the chondrogenic
differentiation of bone marrow-derived mesenchymal stem cells [9,17]. In the following, the term
“medicinal signaling cells” (MSCs) will be used when referring to either mesenchymal stem or stromal
cells [18]. Although original reports on potential complications of nicotine or smoking on articular
cartilage and knee OA have increased in recent years, a systematic analysis of the currently available
basic research has, to the best of our knowledge, not yet been performed. As the nicotine and smoking
dosage could be converted interspecies according to the average body surface area and species-specific
correction factors, a systematic analysis may be important for translating preclinical evidence to the
clinical situation.
Here, we aim to provide an analytical summary of the current preclinical evidence regarding the
association of nicotine/smoking with osteochondrogenesis, osteochondral repair, and OA development.
The following four questions were specifically addressed: (1) Which effects does nicotine have on
the chondrogenesis or osteogenesis of MSCs and articular chondrocytes in vitro? (2) Does PNE have
an effect on cartilage and OA susceptibility in the offspring? (3) Does nicotine/smoking affect OA
development and progression and osteochondral repair in animal models in vivo? and (4) What are the
mechanisms of those effects of nicotine/smoking on the osteochondrogenesis and OA development?
2. Materials and Methods
2.1. Search Strategy
A systematic literature search was performed within the PubMed (1966–2019.09) and ScienceDirect
(1985–2019.09) databases, using the search terms “smoking”, “smokeless tobacco”, “vaping”,
“e-cigarette”, “nicotine”, “cartilage”, and “osteoarthritis”. Studies were enrolled investigating
associations between the nicotine/tobacco/smoking/vaping and osteochondrogenesis, osteochondral
repair, or OA development. Clinical trials, reviews, and non-English articles were excluded.
Two reviewers (L.G. and X.Y.C.) independently screened all articles, and disagreement was resolved
by consultation with a third reviewer (H.M.). All abstracts and titles of the studies were initially
screened. Full texts were then obtained for all studies meeting the inclusion criteria and were reviewed
to reconfirm their eligibility.
2.2. Data Extraction and Critical Appraisal
The data extracted included nicotine dose and cell/animal type, treatment groups, follow-ups,
measures, and main outcomes. Data were collected by one reviewer in a standardized extraction form
and verified by the other two reviewers to reach a consensus. Due to the methodological heterogeneity
of the outcome assessment in the included studies, only data from outcome measures with proven
validity and reliability were further selected and aggregated.
3. Results
3.1. Search Results and the Characteristics of the Included Studies
A total of 842 papers were initially identified. After the removal of duplicates, 472 articles
fulfilled the inclusion criteria (Figure 1). After screening of their titles, abstracts, and full texts with
the aforementioned criteria, 16 articles were finally included: 14 in vitro studies regarding effects of
nicotine or smoke extract on MSCs osteochondrogenesis (Table S1) [9,19–25], osteoblast differentiation
(Table S2) [26,27], and chondrocyte proliferation (Table S3) [7,12,17,28] and six animal studies regarding
the effects of nicotine on osteochondral repair [9] and OA progression (Table S4) [12,15] and the
outcomes of PNE on cartilage formation [28] and OA susceptibility in the offspring (Table S5) [17,29].
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Figure 1. Study selection progress according to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses guidelines [30]. 
3.2. In Vitro Studies 
3.2.1. In Vitro Studies on the Effect of Nicotine on Chondrogenic Differentiation of Medicinal 
Signaling Cells 
3.2.1.1. Bone Marrow-derived MSCs 
Ying et al. reported the effects of nicotine (0, 0.1, 1, and 10 μM) on the proliferation and 
chondrogenesis of human bone marrow-derived (BM) MSCs (BM-MSCs) [22]. Cell viability was not 
significantly impaired in all nicotine groups except for 10 μM nicotine. Cell proliferation was 
increased significantly with both 0.1 and 1 μM nicotine; however, it was inhibited significantly with 
10 μM nicotine. Expression of type-II collagen mRNA and protein was significantly up-regulated 
with 0.1 and 1 μM nicotine, while the expression of aggrecan mRNA was significantly reduced with 
10 μM nicotine. Altogether, the data show a dose-dependent effect of nicotine on the expression of 
chondrogenesis-related genes. 
Deng et al. explored the possible adverse effects of high-dose nicotine (25, 50, and 100 μM) on 
chondrogenesis of rat BM-MSCs [23]. Glycosaminoglycan content was significantly reduced in an 
inverse dose-dependent manner following nicotine treatment. Expression of aggrecan, type-II 
collagen, and IGF-I mRNAs was significantly reduced, indicating that high-doses of nicotine 
suppress the chondrogenic potential of BM-MSCs. 
Figure 1. Study selection progress according to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses guidelines [30].
3.2. In Vitro Studies
3.2.1. In Vitro Studies on the Effect of Nicotine on Chondrogenic Differentiation of Medicinal
Signaling Cells
Bone Marrow-derived MSCs
Ying et al. reported the effects of nicotine (0, 0.1, 1, and 10 µM) on the proliferation and
chondrogenesis of human bone marrow-derived (BM) MSCs (BM-MSCs) [22]. Cell viability was
not significantly impaired in all nicotine groups except for 10 µM nicotine. Cell proliferation was
increased significantly with both 0.1 and 1 µM nicotine; however, it was inhibited significantly with
10 µM ico ine Exp ession of type-II collagen mRNA and protein was significantly up-regulate
with 0.1 and 1 µM nicoti e, while the expr ssion of aggrecan mRNA was significantly reduced with
10 µM nicotine. Altogether, the data show a dose-dependent effect of n cotine on the expression of
chondrogenes s-related genes.
De g et al ex lored the possible adverse effects of high-dose nicotine (25, 50, and 100 µM) on
chondrogenesis of rat BM-MSCs [23]. Glycosamino lycan content was significantly reduce in an
inverse dose-d pendent manner following nicotin tr atment. Expressio of aggrecan, type-II collagen,
and IGF-I mRNAs was significantly reduced, indicating that high-doses of nicotine suppress the
chondrogenic potential of BM-MSCs.
Tie et al. also studied short-term effect of icotine (0.1, 1, 10, and 100 µM) on chondrogenic
diff rentiation of rat BM-MSCs [9]. Expression of sex determini g region Y-type high mobility group
b x 9 (SOX9) mRNA and protein was significantly decreased followi nico ine treatment. Express on
of nucleic nuclear factor of activated T cells (NFATc)-2 protein was significantly elevated and the
cytoplasm phosphorylated NFATc2 was significantly reduced. Additionally, the results also showed
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no effect on the expression of SOX9 when 10 µM methyllycaconitine (MLA) and a short interfering
RNA of NFATc 2 were applied before the nicotine exposure. The data suggest that a nicotine-induced
suppression of SOX9 was initiated via activating the Ca2+/calcineurin/NFATc2 signaling pathway
through α7-nicotine acetylcholine receptor (nAChR).
Adipose-Derived MSCs
Wahl et al. investigated the effect of cigarette smoke extract (CSE) (V/V%; 0, 0.5, 1, 5,
and 10%) on migration and chondrogenesis of human adipose-derived MSCs (AD-MSCs) [19].
0.5% and 1% CSE-treated cells exhibited continual migration without significantly altered cell viability,
5% CSE-treated cells showed reduced viability, while 10% CSE-treated cells scarcely survived. 0.5% and
1% CSE did not significantly alter the metabolic activity and survival of AD-MSCs except at 5% and 10%
CSE. Angiogenic cytokines were significantly inhibited with 0.5% CSE. AD-MSCs treated with 0.5%
CSE had a significantly higher expression of aggrecan and SOX9 mRNAs with reduced mechanical
function. In summary, high-dose CSE (> 5%) exposure drastically impaired the cell migration and
viability, while low-dose CSE (0.5%) inhibited chondrogenesis of AD-MSCs.
Wharton’s Jelly-Derived MSCs
Yang et al. investigated the chondrogenesis of human Wharton’s jelly-derived MSCs (WJ-MSCs)
treated with 5 µM nicotine [24]. Nicotine treatment significantly impaired the proliferation of WJ-MSCs
without alteration of cellular viability. Significantly down-regulated expression of mRNAs (SOX9,
type-II collagen, and aggrecan) and stimulated expression and functional activity of α7-nAChR was
observed at day 28. These data indicate that impaired cellular proliferation and chondrogenesis might
attribute to the functional activity of α7-nAChR with subsequent calcium influx stimulated by the
high-dose nicotine in WJ-MSCs.
3.2.2. In Vitro Studies on the Effects of Nicotine on Articular Chondrocytes
Ying et al. reported the effects of nicotine (0, 0.15, 0.3, and 0.6 µM) on either normal human or OA
knee articular chondrocytes [7]. Nicotine significantly increased cell proliferation of both groups in a
concentration- and time-dependent manner. The level of type-II collagen mRNA was significantly
up-regulated in nicotine-treated chondrocytes compared with the controls. Type-II collagen and
aggrecan protein were significantly higher after nicotine treatment compared with controls in both
groups; however, significantly less in human OA chondrocytes.
Tie et al. investigated the effects of nicotine (0, 0.4, 2, and 10 µM) on neonate rat articular
chondrocytes [17]. Both α4- and β2-nAChR were expressed after 10-day treatment. The Col2a1 mRNA,
aggrecan mRNA, and glycosaminoglycan protein increased significantly in a concentration-dependent
manner. Th expression of catabolic genes was significantly and concentration-dependently suppressed
by nicotine. The expression of mRNAs of the IGF-I signaling pathway was significantly decreased
in a concentration-dependent manner by nicotine. Dihydro-β-erythroidin, a selective α4β2-nAChR
inhibitor, rescued these deleterious effects induced by 10 µM nicotine, suggesting that α4β2-nAchR
mediates the effects of nicotine on articular chondrocytes.
Xie et al. investigated the effect of nicotine (0.1, 1, 10, and 100 µM) on transforming growth
factor-beta (TGF-β) signaling and extracellular matrix (ECM) expression in normal neonatal rat
articular chondrocytes [28]. Nicotine (1, 10, and 100 µM) significantly inhibited the SOX9, Col2a1,
and aggrecan mRNAs expression without affecting cell proliferation and mRNA expression of the
TGF-β signaling pathway. Additionally, 0.1 µM nicotine significantly reduced Col2a1 and aggrecan
mRNAs. Corticosterone (250, 500, and 1250 nM) induced lysine 9 of histone H3 (H3K9) deacetylation
at TGF-βR1 and Col2a1 promoters; however; 100 µM nicotine did not alter the H3K9 acetylation.
These data show that nicotine does not inhibit the TGF-β signaling pathway directly and that the
PNE-induced suppression of TGF-β axis may be mediated by corticosterone.
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Liu et al. investigated the effects of 10 µM nicotine on p38, extracellular signal-regulated
kinase (ERK) 1/2, and c-Jun-N-terminal kinase (JNK) mitogen-activated protein kinases (MAPK)
phosphorylation induced by monosodium iodoacetate (MIA), and IL-1β in adult normal rat
chondrocytes [12]. MIA and IL-1β treatment significantly induced rapid and transient phosphorylation
of p38, ERK1/2 and JNK. 10 µM nicotine pretreatment significantly attenuated MIA- and IL-1β-induced
phosphorylation’s, which could be prevented by MLA.
3.2.3. In Vitro Studies on the Effect of Nicotine on Osteogenic Differentiation of MSCs
Bone Marrow-Derived MSCs
Ng et al. investigated the effects of 1 µM nicotine on the cell proliferation, migration, and
osteogenesis of human BM-MSCs [20]. Calcium deposition and alkaline phosphatase (ALP) content of
MSCs were reduced significantly under osteogenic differentiation with a 10-day nicotine treatment.
Osteogenesis-related and cell migration-related gene expression was significantly down-regulated
following the nicotine treatment, suggesting that nicotine inhibits osteoblastic differentiation
of BM-MSCs.
Shaito et al. studied the effects of e-cigarette smoke extract on osteogenic differentiation of human
BM-MSCs, demonstrating that the smoke extract significantly decreased type-I collagen and Runx2
expression, altered cellular morphology with less mineralization, and generated more reactive oxygen
species [25].
Periodontal Ligament-Derived Signaling Cells
Ng et al. also investigated similar studies with human periodontal ligament-derived signaling
cells (PDLSCs) [20]. Cell proliferation and migration of 1 µM nicotine-treated PDLSCs were
significantly reduced. Osteogenesis-related miRNAs were significantly up-regulated following nicotine
treatment. Subsequent gene expression analysis identified significantly down-regulated expressions of
osteogenesis-related genes, further supporting the inhibitory effect of nicotine on PDLSCs osteogenic
differentiation potential.
Ng et al. further studied the osteogenic potential of PDLSCs harvested from cigarette
smokers [21]. Cell proliferation and migration were significantly reduced compared with non-smokers.
Calcium deposition and ALP activity were significantly reduced in PDLSCs from smokers with induced
osteogenesis differentiation. Furthermore, nicotine-related miRNAs were significantly up-regulated in
PDLSCs from smokers, suggesting their possible important roles in the deteriorative effects on PDLSCs
by cigarette smoke.
Adipose-Derived MSCs
Wahl and colleagues investigated the effect of CSE exposure on the osteogenesis of AD-MSCs [19].
The osteogenic differentiation was reduced with the inhibited expression of early osteogenic makers after
a three-day 0.5% CSE exposure, but it was gradually recovered after a one-week period with significantly
increased expression of the late osteoblastic marker osteocalcin, suggesting that osteogenesis inhibited
by low-dose CSE may be recovered over time.
3.2.4. In Vitro Studies of Effects of Smokeless Tobacco Extract (STE) on Osteoblast Differentiation
Lenz et al. studied the effects of smokeless tobacco extract (STE) on osteoblasts obtained from
chick embryo clavarias and found that STE irreversibly inhibited osteoblastic differentiation with
decreased bone collagen synthesis [27]. Henderson et al. showed that diluted STE influenced osteoblast
proliferation, differentiation, and metabolism in a dose-dependent manner [26].
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3.3. Animal Studies
Six animal studies were identified investigating possible effects of PNE or nicotine on articular
cartilage development and OA susceptibility in offspring. Deleterious effects of PNE were reported on
cartilage quality and the OA susceptibility in adult offspring. Additionally, the animal studies
demonstrated that nicotine negatively influenced osteochondral defect repair and suppressed
MIA-induced cartilage degradation in a dose-dependent fashion.
3.3.1. Effect of Nicotine on Cartilage Formation in the Offspring
Xie et al. showed that PNE intergenerationally programs impaired articular cartilage via histone
deacetylation through maternal lineage [28]. Significantly impaired formation of cartilage in both
PNE-F1 and PNE-F2 offspring, reduced ECM expression, and weakened TGF-β signaling in adults
were observed. In both neonatal and adult offspring, significantly inhibited acetylation of H3K9
gene promoters was detected. Fewer cells and significantly reduced extracellular matrix staining was
noticed within the articular cartilage of all offspring with reduced Col2a1 expression. In the adult
PNE-F2 offspring, the deacetylation at H3K9 of the TGF-βR1 and Col2a1 promoters, directly induced
by corticosterone (rather than nicotine), might be involved in the diminished cartilage formation in
adult PNE-F2 offspring.
3.3.2. Effect of Nicotine on OA Susceptibility in Offspring
Tie et al. demonstrated the effects of PNE on rat OA susceptibility after strenuous running in
adult F1 offspring following subcutaneous injections of nicotine during the gestational days 11–20 [17].
Interestingly, birth weight was significantly decreased, and the intrauterine growth retardation rate was
significantly increased in the PNE group. Likewise, significantly elevated serum corticosterone and
reduced IGF-I concentrations were observed in the PNE neonates. Expression of IGF-I, serine-threonine
protein kinase 12 , and SOX9 protein was significantly reduced in PNE neonates and adult offspring.
Expression of Col2a1 mRNA and protein was significantly decreased in both PNE and control
groups. The data revealed that PNE impeded the expression of the SOX9, Col2a1, and IGF-I signaling
pathways in articular cartilage of offspring with increased OA susceptibility. By qualitative macroscopic
examination, knee joints from the PNE group with strenuous running showed more cartilage erosions
than the control group, while PNE had no effect under nonrunning conditions. Histological scoring
was significantly worse in the PNE group with strenuous running compared with the normal control
group, while no effects under no running conditions were seen. Moreover, significant less Col2a1 was
present in the cartilage of the PNE rats in both the no running and running groups, suggesting that
PNE inhibits the synthesis of type-II collagen and increases the susceptibility of adult offspring to OA
when challenged.
Tie et al. also evaluated the articular cartilage of adult rat offspring fed with a high-fat diet from
rats intragestationally treated with subcutaneous nicotine injection [29]. Significantly increased IGF-I,
total cholesterol, and low-density lipoprotein cholesterol, and decreased corticosterone levels were
observed in the PNE group. Significantly decreased expression of Col2a1 mRNA in neonates and
expression of IGF-I, liver X receptor β, adenosine triphosphate-binding cassette transporter A1 and
Col2a1 in both neonates and adult offspring were reduced in the PNE group. Significantly worse
histological scores were observed in the PNE group. Thus, PNE induced impaired articular cartilage
quality in adult offspring and increased OA susceptibility.
3.3.3. Effect of Nicotine in Animal Models of OA
Liu et al. investigated the effects of nicotine on MIA-induced articular cartilage degradation
in adult Sprague-Dawley rats treated with intraperitoneal nicotine injections [12]. Interestingly,
nicotine reduced macroscopic and histological indices of joint degradation, although the data also
implied that nicotine did not fully prevent MIA-induced cartilage degeneration. Administration
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of the α7-nAChR-selective antagonist methyllycaconitine (MLA) abolished these protective effects.
Teng et al. reported the effects of nicotine on MIA-induced cartilage degradation in adult mice treated
with intraperitoneal nicotine injection [15]. Nicotine significantly attenuated OA-induced mechanical
allodynia in a dose-dependent manner. However, MLA significantly reversed the analgesic effect
of nicotine. Nicotine significantly reduced cartilage degradation also in a dose-dependent manner
and the upregulation of matrix metalloproteinase 9 (MMP-9), a hallmark of joint inflammation in
OA. The activities of MMP-9 were significantly increased by MIA treatment and reduced by nicotine
treatment. Furthermore, MLA pretreatment blocked the suppressive effect of nicotine on the MMP-9
expression. The data of these 2 studied suggest that nicotine suppresses MIA-induced cartilage
degradation in mice and rats by activating the α7-nAChR.
3.3.4. Effect of Nicotine on Osteochondral Repair
Tie et al. investigated the effect of nicotine on the repair of focal osteochondral trochlear defects in
adult rats treated with BM-MSCs encapsulated in alginate [9]. Postoperative subcutaneous nicotine
injections yielded significantly worse macroscopic and histological scores of osteochondral defect
repair. Reduced expression of Col2a1, aggrecan, and SOX9 mRNAs was observed, possibly related to
the negative influence of nicotine on the osteochondral repair.
4. Discussion
This systematic review provides a summary of the current preclinical evidence of the effects
of nicotine/smoking on MSCs and chondrocytes in vitro and OA development and osteochondral
repair in vivo. Altogether, the data show that nicotine has dose-dependent effects on both articular
chondrocytes and on the chondrogenesis and osteogenesis of MSCs in vitro, with lower doses often
leading to positive effects while higher doses causing negative effects in different in vitro models.
PNE negatively affects articular cartilage development and induces OA in offspring without or with
nicotine exposure in small animal models. In contrast, protective effects on OA development were only
reported in MIA-induced small animal models. Finally, nicotine repressed MSC-based osteochondral
repair in vivo.
Nicotine has a dose-dependent effect on chondrogenic differentiation of MSCs and articular
chondrocytes in vitro and on cartilage formation in animal models. Such a dose-dependence describes
the magnitude of the response of an organism, as a function of doses to a stimulus or stressor after
a certain exposure time [31,32]. In vitro studies demonstrated the dose-dependent effect of nicotine
on articular chondrocytes and MSCs [7,17,28]. However, the dose-dependent effects were seen in a
time-dependent manner [9,19,22–24]. In animal models, Xie et al. reported that nicotine suppressed the
formation of cartilage in adults of PNE-F1 and PNE-F2 offspring [28]. As only one concentration was
tested, more translational in vivo studies are warranted to further investigate the effects of different
dose ranges of nicotine on articular cartilage formation.
Such a dose-dependent effect of nicotine/smoking might be explained by the selective stimulation of
the different types of nAChR with calcium influx (Figure 2) [9,17,24]. The neuronal nAChR subunits are
currently classified into theα-type and theβ-type in a neuron. A limited number ofαβ orα-only subunit
combinations have been found to form functional pentameric ion channels. The most common and
widely distributed combinations of subunits are α7 and α4β2 [33]. MSCs and articular chondrocytes
express both α7-nAChR and α4β2-nAChR [9,15,17,24]. Stimulation of nAChR accompanied by
low-functional programming of IGF-I subsequently promoted chondrocyte proliferation through
the phosphorylation of the ERK/MAPK pathway [17]. Moreover, evidence showed that SOX9
expression is regulated by the phosphatidylinositol-3-kinase/protein kinase B pathway and the
Ca2+/calcineurin/NFATc2 signaling pathway [9]. However, the precise mechanism of such a selective
stimulation of nAChR after nicotine exposure is not yet completely understood.
Nicotine also has a dose-dependent effect on the quality of the articular cartilage in adult offspring,
OA susceptibility of offspring, and severity of MIA-induced OA. In animals, Tie et al. reported that
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PNE induced impaired articular cartilage quality in adult offspring and increased OA susceptibility
of offspring [19,28]. However, the studies by Liu and Teng suggested that nicotine suppressed
MIA-induced OA in animals with a dose of 0.5 or 1.0 mg/kg/d.
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epidemiologic investigation based on 173,687 malformed cases and 11.7 million controls revealed that 
maternal smoking was associated with birth defects, including congenital osteochondral defects [35]. 
Additionally, Tie et al. demonstrated PNE induced fetal overexposure to maternal glucocorticoids, 
repressing the IGF-I expression in the fetus and inducing the intrauterine growth retardation [17]. 
Xie et al. also reported that corticosterone suppressed the expression of mRNAs related to SOX9, 
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Figure 2. Schematic of nicotine-mediated signaling pathway with the stimulation of (α7)5 nicotine
acetylcholine receptor (nAchR) and (α4)2(β2)3 nAchR. CaN, Calcineurin; DhβE, Dihydro-β-erythroidine,
HDAC, histone deacetylase; H3K9, histone H3K9; H3K14, histone H3K14; MLA, methyllycaconitine;
NFAT, nuclear factor of activated T cells; NFATc2, nuclear factor of activated T cells 2; P, phosphorylation.
This preclinical evidence suggest that a dosage threshold might exist at which the negative effects
of nicotine begin and thus may be avoided. The dose of nicotine exposure (0.5 and 1 mg/kg/d) for the
available mice study is equivalent to 2 and 4 cigarettes/day for a 60 kg human. The arterial nicotine
concentration was reported ranging from 0.12 to 0.6 µM after smoking one cigarette [34]; therefore, the
dose of nicotine exposure as 0.5 and 1 mg/kg/d in animals may be equivalent less than 1 µM nicotine.
Else, the epidemiologic evidence in humans highlighted the negative effects of cigarette smoking on
knee osteochondral repair and joint degeneration, surfacing as cartilage loss and defect development
primarily in individuals with an OA family history [13]. A recent meta-analysis reported that smokers
had less radiographic OA than non-smokers [14]; however, men who smoke might die from other
smoking-related diseases such as esophageal or lung cancer before OA may develop.
PNE induced an imperfect cartilage quality in offspring. Xie et al. showed that PNE
intergenerationally programs impaired articular cartilage through maternal lineage [28]. A previous
epidemiologic investigation based on 173,687 malformed cases and 11.7 million controls revealed that
maternal smoking was associated with birth defects, including congenital osteochondral defects [35].
Additionally, Tie et al. demonstrated PNE induced fetal overexposure to maternal glucocorticoids,
repressing the IGF-I expression in the fetus and inducing the intrauterine growth retardation [17].
Xie et al. also reported that corticosterone suppressed the expression of mRNAs related to SOX9,
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Col2a1, aggrecan, and TGF-β pathway components [28]. The acetylation modifications H3K9ac in
TGF-βR1 and Col2a1 promoter were significantly reduced with 1250 nM corticosterone, and its inhibitor
reversed such effects, however, 100 µM nicotine did not alter the acetylation at H3K9. These data
indicate that corticosterone might mediate the intergenerational transmission of imperfect cartilage by
PNE through the alteration of histone acetylation.
Finally, nicotine negatively influenced MSC-based osteochondral repair, perhaps through a
decreased expression of Col2a1 following suppressing of SOX9 in a rat model [9]. This report is in
good agreement with the known inhibitory effects of nicotine on MSC chondrogenesis in vitro [9,22,23]
since MSC is a key cell type involved in spontaneous and therapeutic osteochondral repair [36,37].
This systematic review holds some limitations. A source of selection bias is inherent in the study
inclusion criteria related to the use of only English language studies. Other sources of potential
selection, performance, and detection bias include the analysis of only the knee joint in the animal
experiments (versus other musculoskeletal regions and tissue types, which likely are equally affected by
the systemic effects of smoking). As a result of these differences, it becomes a challenge to generalize and
draw conclusions between the various studies with several different variables. No clinical study was
included, which is outside of the scope of this work, focusing solely on in vitro and translational data.
For the future, the key question remains whether a threshold exists for the specific pathologies
at which the negative effects of nicotine begin, and therefore, may be avoided, necessitating more
specific investigations into dose-dependent clinical effects of smoking on cartilage quality in offspring,
OA susceptibility and progression and osteochondral repair.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/8/10/1699/s1,
Table S1: In vitro studies of effects of nicotine on chondrogenesis and osteogenesis of medicinal signaling cells,
Table S2: In vitro studies of effects of smokers tobacco extract (STE) on osteoblast differentiation, Table S3: In vitro
studies of effects of nicotine on articular chondrocytes, Table S4: Animal study of effect of nicotine on cartilage
defect repair and OA, Table S5: Effects of prenatal nicotine exposure of animals knee cartilage development and
OA susceptibility in offspring.
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